Diabetes medications and dementia risk: Comparisons of SGLT2 inhibitors, GLP-1 RAs, metformin, and their combinations

Diabetes Epidemiology and Management · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles